← Home / IDEAYA Biosciences, Inc. (IDYA)
Stock Analysis

IDEAYA Biosciences, Inc. (IDYA)

IDYA
IDYA · Healthcare • Biotechnology
39.93 -0.60%
Track IDYA in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when IDYA price is:
52W Range Position
87%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-09-03 21:42 UTC
WOI Investment Thesis
Constructive
Current market structure would strengthen above 40.58. Holding above 35.80 preserves the current price structure.
⚖️
✓
Fundamentals
Weak / Negative / Pressured / Strong
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
35.80
↗
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
40.58
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
4
●
Financial Results
HIGH
IDYA reports financial results
Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $0.0001 par value per share IDYA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Ru...
8-K Filing • SEC EDGAR
JUN
10
↗
Equity Offering / Capital Raise
HIGH
IDYA equity financing update
Underwriting Agreement On June 8, 2026, IDEAYA Biosciences, Inc.
8-K Filing • SEC EDGAR
MAY
5
↗
Equity Offering / Capital Raise
HIGH
IDYA equity financing update
On May 5, 2026, IDEAYA Biosciences, Inc.
8-K Filing • SEC EDGAR
What's Driving IDYA?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Revenue growth is weak. Profitability is negative. Cash generation is pressured. Balance-sheet quality is strong.
⚠️ Key risk remains
Below 35.80
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
58.3
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 35.80 and resistance at 40.58. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
IDYA — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-09-02
Cash
Cash-flow pressure
TTM free cash flow is negative. P/FCF and FCF yield should be read with caution.
Market Cap
$3.9B
Company size
EV
$3.1B
Debt-adjusted value
P/S
16.5
Premium
P/B
3.2
Balanced
EV/Sales
13.0
Premium
EV/EBIT
-0.9
Not meaningful
FCF Yield
-1.84%
Cash return
Not financial advice
Business Lens
Financial pressure is elevated
Financial conditions require selective monitoring.
↗
Revenue Growth
Weak
●
Profitability
Negative
≈
Cash Flow
Pressured
⚖
Balance Sheet
Strong
💵 Revenue
8.86M
↘ Weak
📈 Net Income
-112.45M
↘ Negative
🧮 EPS (Basic)
-1.22
↘ Negative
IDEAYA Biosciences, Inc.
Healthcare • Biotechnology
You Might Also Like